DIXON:NSEDixon Technologies (India) Ltd. Analysis
Data as of 2026-03-14 - not real-time
₹10,338.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Dixon Technologies is trading at INR 10,338, well below its 20‑day SMA of 10,689, indicating short‑term weakness. The 50‑day SMA (11,010) and 200‑day SMA (14,479) remain higher, confirming a bearish medium‑term bias. RSI sits at 44, suggesting the stock is not yet oversold but lacks bullish momentum. MACD has turned positive with the histogram at +39, offering a tentative bullish signal amid the overall bearish trend. Volume is increasing, and the price is testing the support at INR 9,630, while resistance lies near INR 11,839.
The company posted a modest 2.1% YoY revenue growth to ₹10,678 crore in Q3 FY26, with EBITDA up 5.8% to ₹421 crore. However, EPS forecasts have been trimmed by 6‑16% for FY26‑28, reflecting uncertainty around future earnings expansion. Valuation is stretched at a forward P/E of 50.6 versus the industry average of 33.7, and the price‑to‑book of 13.8 further underscores premium pricing. Dividend yield is low at 0.08% with a payout ratio of just 3%, raising questions about dividend sustainability. The stock’s beta of –0.22 points to low market correlation, but 30‑day volatility exceeds 53%, indicating sharp price swings. The fear‑greed index reading of “Greed” (72.9) suggests market optimism may be overstated. Given the blend of technical resilience, modest top‑line growth, and elevated valuation, the upside potential is limited to roughly 27% while downside risk remains significant.
The company posted a modest 2.1% YoY revenue growth to ₹10,678 crore in Q3 FY26, with EBITDA up 5.8% to ₹421 crore. However, EPS forecasts have been trimmed by 6‑16% for FY26‑28, reflecting uncertainty around future earnings expansion. Valuation is stretched at a forward P/E of 50.6 versus the industry average of 33.7, and the price‑to‑book of 13.8 further underscores premium pricing. Dividend yield is low at 0.08% with a payout ratio of just 3%, raising questions about dividend sustainability. The stock’s beta of –0.22 points to low market correlation, but 30‑day volatility exceeds 53%, indicating sharp price swings. The fear‑greed index reading of “Greed” (72.9) suggests market optimism may be overstated. Given the blend of technical resilience, modest top‑line growth, and elevated valuation, the upside potential is limited to roughly 27% while downside risk remains significant.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- price near key support level
- bearish SMA hierarchy
- high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- modest revenue and EBITDA growth
- valuation premium relative to peers
- recent EPS estimate cuts
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- diversified product portfolio and export exposure
- low beta indicating limited market correlation
- potential for long‑term industry tailwinds
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin3.25%
P/E Ratio37.6
Debt/Equity29.66
P/B Ratio13.8
Industry P/E33.7
Technical Analysis
TrendBearish
RSI44.4
Support₹9,630.00
Resistance₹11,839.00
MA 20₹10,689.90
MA 50₹11,010.16
MA 200₹14,478.80
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price₹13,114.41
Upside/Downside26.86%
GradeOvervalued
TypeBlend
Dividend Yield0.08%
Risk Assessment
Beta-0.22
Volatility53.21%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.